Key result
Verapamil SR, enalapril, and nitrendipine reduced 24-hour mean blood pressure compared to placebo, with verapamil and enalapril more effectively lowering nighttime blood pressure than nitrendipine.
Why the study?
Ambulatory blood pressure monitoring has potential advantages over conventional measurement but its routine use in treating hypertensives is limited by lack of prognostic validity and high cost.
Does ambulatory blood pressure monitoring better evaluate the efficacy of antihypertensive drugs compared to conventional measurement?
RCT
Double-blind
parallel group
Yes
Does ambulatory blood pressure monitoring better evaluate the efficacy of antihypertensive drugs compared to conventional measurement?
Ambulatory blood pressure monitoring can detect differences in the 24-hour efficacy profile of antihypertensive drugs that are missed by conventional sphygmomanometry.
Answers are grounded in this paper and cite their sources.
ABPM lacks prognostic validity for routine antihypertensive evaluation; leaves open targeted use in research or high-risk subgroups.
Ambulatory blood pressure monitoring is becoming increasingly popular among clinicians and investigators because of its potential to overcome the well-known limitations inherent to conventional blood pressure measurement. This paper will focus on the use of this approach in the evaluation of antihypertensive treatment. It will be argued that due to lack of prognostic validity and high cost, ABPM should not be employed routinely in treating hypertensives. It should always be employed, however, for the evaluation of the efficacy of new hypertensive drugs for which its superiority over sphygmomanometry is indisputable. This is exemplified by the results of a recent multicenter, double-blind, parallel group study on the effect of verapamil SR 240 mg, enalapril 20 mg and nitrendipine 20 mg and placebo, all administered once a day for eight weeks. Compared to placebo, all drugs reduced 24-hour mean blood pressure sufficiently. The reduction was evident throughout the daytime but nighttime blood pressure was more effectively lowered by verapamil and enalapril than by nitrendipine, documenting a difference that was not visible by using conventional measurements.
No takes yet. Share an insight, caveat, or question.
Mancia et al. (1992) conducted an RCT in Hypertension. Verapamil SR, enalapril, and nitrendipine vs. Placebo was evaluated on 24-hour mean blood pressure reduction. Verapamil SR, enalapril, and nitrendipine reduced 24-hour mean blood pressure compared to placebo, with verapamil and enalapril more effectively lowering nighttime blood pressure than nitrendipine.
Synapse has enriched 10 related papers. Consider them for comparative context: